Every batch ships straight from the lab that synthesises it — sealed, tamper-evident, and HPLC-verified to >99% purity . Buying direct means you pay the lab-direct rate on every vial, with nothing stacked on top.

Order a full sealed 10-vial research pack for a complete study supply, or add a single-vial sample alongside your pack to trial a new compound first. Same lab, same batch, same verified purity — scaled to whatever your research needs.

What It's Researched For

In plain terms, Klow is the Glow blend with an anti-inflammatory peptide added. Here is what that looks like across the research.

Inflammation signalling

KPV is the fragment of alpha-MSH studied for damping inflammatory signalling — the arm Glow does not have.

Matrix and collagen research

GHK-Cu, the copper tripeptide, remains the largest component by mass and carries the strongest independent literature.

Tissue-repair signalling

BPC-157 and TB-500 cover angiogenesis and cell migration, the two most-cited peptide repair pathways.

Fewer handling steps

One vial, one reconstitution — instead of measuring and mixing four separate lyophilised powders.

Overview

In short: Klow is a fixed research blend of KPV, GHK-Cu, BPC-157 and TB-500 — 80 mg of total peptide per vial, adding an anti-inflammatory tripeptide to the Glow composition.

Key research facts

Four research compounds pre-combined in a single vial — one reconstitution instead of four

KPV (10 mg): alpha-MSH C-terminal tripeptide studied for anti-inflammatory signalling

GHK-Cu (50 mg): copper-binding tripeptide studied for matrix remodelling and collagen signalling

BPC-157 (10 mg): pentadecapeptide studied for angiogenic and tissue-repair pathways

TB-500 (10 mg): thymosin beta-4 fragment studied for actin binding and cell migration

Research use only. These points summarise lab themes, not human outcomes.

Klow is the Glow blend plus one compound. The GHK-Cu, BPC-157 and TB-500 quantities are identical — 50 mg, 10 mg and 10 mg — and KPV is added at 10 mg, taking the vial from 70 mg to 80 mg of total peptide. The reason for a separate SKU rather than a variant is that KPV addresses a different research question from the other three.

KPV is the C-terminal tripeptide (Lys-Pro-Val) of alpha-melanocyte-stimulating hormone. Where the parent hormone acts through melanocortin receptors, the KPV fragment is studied for anti-inflammatory activity that appears to operate independently of them — a distinction that has kept it in the literature as a probe for inflammatory signalling rather than pigmentation. The other three components bring matrix remodelling (GHK-Cu), angiogenic signalling (BPC-157) and actin binding (TB-500).

As with Glow, the blend has no literature of its own. No pharmacokinetic or efficacy study exists for these four administered together, and combining them does not merge their half-lives or clearance routes. One format caveat is worth noting: much of the published KPV work uses oral or topical administration, which an injectable blend does not reproduce. Klow is supplied as research-grade lyophilised powder for in-vitro and preclinical work only, and nothing on this page is medical advice.

Mechanism of Action

Klow has no combined mechanism — it is four independent research compounds sharing a vial. KPV is studied for melanocortin-independent anti-inflammatory signalling, GHK-Cu for copper-complex matrix signalling, BPC-157 for angiogenic pathways and TB-500 for actin binding.

Pathway Effect Why it matters KPV — inflammatory signalling Alpha-MSH C-terminal fragment studied for NF-κB pathway modulation in cell models The component that distinguishes Klow from Glow GHK-Cu — matrix remodelling Copper-binding tripeptide studied for collagen, decorin and elastin signalling The dominant component by mass (50 of 80 mg) BPC-157 — angiogenic signalling Studied for VEGFR2 pathway activation and tissue-repair signalling The most-cited compound in peptide repair research TB-500 — actin binding Thymosin beta-4 fragment studied for actin sequestration and cell migration Complements BPC-157 in repair-model work

Deeper dive for scientific readers

Klow is a supply format rather than a pharmacological entity, and the same caveats that apply to Glow apply here with one addition. No study has characterised these four compounds administered together — no combined pharmacokinetics, no interaction data, no evidence bearing on the fixed 10:50:10:10 ratio. KPV introduces a specific format mismatch: the published KPV literature leans heavily on oral and topical routes, where its small size and stability are advantages, and an injectable blend does not reproduce those delivery conditions. Researchers designing around KPV should be explicit about that gap rather than assuming route equivalence. The remaining three components behave exactly as they do in Glow, with individual half-lives and clearance routes unaffected by sharing a vial.

Common Questions People Are Asking

What is in the Klow stack?

Each vial contains KPV 10 mg, GHK-Cu 50 mg, BPC-157 10 mg and TB-500 10 mg — 80 mg of total peptide. The ratio is fixed across every vial in the pack. All four components are available individually, and the Glow blend supplies the same three non-KPV components at identical quantities. It is supplied for laboratory research only and is not for human use.

What is the difference between Klow and Glow?

KPV. Klow is the Glow composition — GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg — with KPV added at 10 mg, taking the vial from 70 mg to 80 mg. Nothing else changes. Because the shared components are at identical quantities, the two blends can be compared directly.

What is KPV and why is it in this blend?

KPV is the C-terminal tripeptide (Lys-Pro-Val) of alpha-melanocyte-stimulating hormone. It is studied for anti-inflammatory signalling that appears to operate independently of the melanocortin receptors the parent hormone acts through. It adds an inflammation-research arm that the other three components do not cover. Note that most published KPV work uses oral or topical routes rather than injection.

Is there research on the four compounds used together?

No. No pharmacokinetic, safety or efficacy study has examined KPV, GHK-Cu, BPC-157 and TB-500 administered as a fixed blend, and no interaction data exists. The individual components have separate literatures of varying strength, but component evidence does not transfer to a combination. Design protocols from the component literature.

How should the Klow stack be stored?

Keep the lyophilised powder frozen at −20 °C. After reconstitution with bacteriostatic water or sterile saline, refrigerate at 1–6 °C and protect from light. Because the vial contains four compounds with different stability characteristics, use it within the validated window for the batch rather than extrapolating from any single component.

Where can I buy Klow?

Right here — Klow is supplied directly by New-U Research Compounds on this page. Every batch is independently third-party tested to >99% HPLC purity with a batch-linked Certificate of Analysis, supplied as lyophilised research-grade material, and shipped direct from source worldwide in discreet, tracked packaging. Strictly for laboratory research use only — not for human use.

How much does Klow cost?

Klow pricing is shown live on this page, per pack size — 10-vial research packs as standard, with single-vial sample options on selected compounds. Larger vial strengths lower the per-mg cost, every order includes the batch Certificate of Analysis, and shipping is free on orders over $300.

Is Klow third-party tested?

Yes. Every Klow batch is verified by independent laboratories (Janoshik Analytics and Freedom Diagnostics) for identity and purity, with a batch-linked Certificate of Analysis confirming >99% purity by HPLC. Every order ships with its COA, and current batch certificates are published on our COA page.

How do I buy Klow?

Add the Klow pack size you need to your cart and check out: enter your shipping details, then choose your payment method — cryptocurrency or card — on the next step. Every order ships with its batch Certificate of Analysis (COA). Klow is supplied strictly for laboratory research use only, not for human or veterinary use.

What payment methods can I use to buy Klow?

At checkout you can pay by cryptocurrency (BTC, ETH, SOL, LTC, USDC, USDT and more) or by card, each handled by a dedicated secure payment provider. You choose your method after confirming your order.

How fast is shipping, and do you ship worldwide?

Yes — we ship worldwide in discreet, unmarked, temperature-stable, tracked packaging. Delivery typically takes 6–14 business days, and shipping is free on orders over $300.

Is it legal to buy Klow?

In the United States, Klow is sold strictly for laboratory and research purposes only. It is not approved by the FDA for human consumption and is not sold for that purpose. Regulatory status varies by jurisdiction — buyers are responsible for compliance in their own region.

Pharmacokinetics

Stability Lyophilised powder: store in freezer (−20 °C). Reconstituted: refrigerate 1–6 °C, away from sunlight. Use within the validated stability window for the specific batch and formulation. Notes No pharmacokinetic study exists for the four compounds administered as a fixed blend — they have distinct half-lives and clearance routes, and combining them does not create a shared profile. KPV in particular is often studied by oral and topical routes in the published literature, which the injectable blend format does not reproduce. Any protocol should be derived from the individual component literature. These figures describe published research and are not a dosing recommendation.

Evidence Tier

Overall: Tier 3: Anecdotal / self-report

Klow itself has no evidence base: no pharmacokinetic, safety or efficacy study has examined KPV, GHK-Cu, BPC-157 and TB-500 administered as a fixed blend, and no interaction data exists. The components have separate literatures of varying strength — GHK-Cu's is the most substantial, KPV's is largely oral and topical rather than injectable — but component evidence does not transfer to a combination product. The blend has no regulatory approval in any jurisdiction and is supplied as unapproved laboratory material.

Source References & Further Reading

Last reviewed: 29 July 2026 · New-U Research Compounds

PubMed: peer-reviewed literature on Klow

ClinicalTrials.gov: registered studies on Klow

Klow: Wikipedia (search)

WebMD: consumer health reference

BBC News: Health

CNN Health: “Peptides: what to know about the wellness trend”

Sky News: “Can peptides make America healthy again?”

Sky News: “Inside the exploding US peptides craze” (video)

Sky News Australia: “Black market peptide trade explodes as influencers fuel uptick in use”

Sky News Australia: “Backyard peptide boom sparks alarm” (video)

Sky News Australia: “Oprah reveals struggle with shame of weight-loss drugs”

Key Characteristics

Fixed four-compound blend: KPV 10 mg + GHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg

80 mg total peptide per vial

Identical to Glow apart from the added KPV

KPV is the C-terminal tripeptide (Lys-Pro-Val) of alpha-MSH

KPV research is largely oral and topical — the injectable format differs

No combined pharmacokinetic or interaction data exists for the blend

Component protocols must be derived from the individual literature

Research-grade purity: >99% HPLC per component

Specifications

Composition KPV 10 mg + GHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg Total Peptide 80 mg per vial KPV Lys-Pro-Val, alpha-MSH (11-13) fragment, 342.44 Da GHK-Cu Gly-His-Lys copper complex, 340.42 Da (free tripeptide) BPC-157 GEPPPGKPADDAGLV, 1419.53 Da TB-500 Thymosin beta-4 (17-23) actin-binding fragment Purity >99% (HPLC), per component Form Lyophilised powder Solubility Bacteriostatic water or sterile saline Storage Lyophilised: −20 °C freezer. Reconstituted: 1-6 °C, away from light.

About the Klow Stack: KPV, GHK-Cu, BPC-157 and TB-500 Research Blend Guide

Klow takes the Glow composition — GHK-Cu, BPC-157 and TB-500 — and adds KPV at 10 mg, bringing each vial to 80 mg of total peptide. The three shared components are present at identical quantities, so the two blends are directly comparable, which is unusual and useful: it means the marginal contribution of KPV can in principle be isolated in a research setting.

KPV is the piece worth understanding, because it is the reason the SKU exists. It is the C-terminal tripeptide of alpha-melanocyte-stimulating hormone — just three residues, Lys-Pro-Val. The parent hormone signals through melanocortin receptors and is best known for pigmentation, but the KPV fragment is studied for anti-inflammatory activity that appears to work independently of those receptors, which is what has kept it in the inflammation literature. That literature, however, leans heavily on oral and topical administration, where a small stable tripeptide has real delivery advantages. An injectable blend does not reproduce those conditions, and that gap should be stated in any protocol rather than assumed away.

The blend as a whole has no literature. No study has characterised these four compounds administered together, so there is no combined pharmacokinetics, no interaction data and no evidence bearing on whether the fixed 10:50:10:10 ratio is optimal for anything. New-U Research Compounds supplies Klow as a research-grade lyophilised powder with a batch certificate of analysis. All material is strictly for in-vitro and preclinical research use. It is not approved for human therapeutic use in any jurisdiction, and nothing on this page constitutes medical advice or a dosing recommendation.

Alpha-melanocyte-stimulating hormone - Wikipedia

Copper peptide GHK-Cu - Wikipedia

BPC-157 - Wikipedia

Thymosin beta-4 - Wikipedia

Customer Reviews

No customer reviews yet — be the first to share your experience.

More in Stacks

BPC+TB 5mg Combo

BPC+TB 10mg Combo

Glow

Klow vs related Stacks compounds

Compound Price Purity spec COA Klow from $369 >99% HPLC (per component) On request BPC+TB 5mg Combo from $169 >99% HPLC (per component) On request BPC+TB 10mg Combo from $279 >99% HPLC (per component) On request

Descriptive catalog comparison for research sourcing decisions — not dosing guidance. All compounds are for laboratory research use only.

More on Klow

Klow research guide

Research use only — not for human consumption. All products are supplied strictly for laboratory research purposes.